OmniGen Research, LLC
USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23K (Fodder).
The verdict
According to USPTO PatentsView, Omnigen ranks #42,105 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.
- #42,105
- of 49,997 US assignees by volume
- Top 20%
- by Innovation Score (46.6/100)
- 17.5
- avg claims per patent
- +100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R42105 · US Corporation #42,105 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #42,105/49,997
- PHOTO-FINISH Oklo
- CPC-NARROW A23K · 7 areas
- INNOV-PAR 46.6/100
- CLAIMS-RICH 17.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Oklo Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Omnigen’s 46.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Omnigen
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- OmniGen Research · this assignee
OmniGen Research · this assignee
47 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Omnigen's Innovation Score is 46.6/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Omnigen?
Each dot is one of Omnigen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Omnigen’s own 17.5 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Omnigen's grants concentrate
OmniGen Research, LLC is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A23K (Fodder). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2020. By volume, Omnigen sits between Oklo Inc. and One Source Industries, LLC.
Omnigen's three-year grant acceleration
OmniGen Research, LLC shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at OmniGen's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Oklo
Oklo Inc.
6 patents
- Oktober
Oktober, LLC
6 patents
- Oleg Illiich Epsh…
Oleg Illiich Epshtein
6 patents
- Olink Proteomics…
Olink Proteomics AB
6 patents
- Omnicare
Omnicare, LLC
6 patents
- Omron Adept
Omron Adept Technologies, Inc.
6 patents
- One Health Group
One Health Group, Inc.
6 patents
- One Source Indust…
One Source Industries, LLC
6 patents
- Omnigen Research ◀
OmniGen Research, LLC
6 patents
What this shows OmniGen holds 6 patents at rank #42,130, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near OmniGen
By rank, the assignees closest to #42,130 in granted patent volume.
- Oklo Inc. #42,126 · 6 patents
- Oktober, LLC #42,127 · 6 patents
- Oleg Illiich Epshtein #42,128 · 6 patents
- Olink Proteomics AB #42,129 · 6 patents
- Omnicare, LLC #42,131 · 6 patents
- Omron Adept Technologies, Inc. #42,132 · 6 patents
- One Health Group, Inc. #42,133 · 6 patents
- One Source Industries, LLC #42,134 · 6 patents
Leaders in A23K (Fodder)
Other assignees with the most granted patents in OmniGen's primary technology class.
Omnigen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 33.3% |
| 2020 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 2 | 33.3% |
Which technologies does OmniGen Research, LLC patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
OmniGen Research, LLC's patent record in context - here's where to go next.
- OmniGen Research, LLC's lead technology class is A23K (Fodder), 100% of its portfolio - see every assignee active in that class. Explore A23K
- Ranked #42,105 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare OmniGen Research, LLC against Oklo Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.